News

Anvisa approves two new Cannabis based products

Now Brasil has seven Cannabis sativa extracts approved by the Agency.
One of them is Promediol™ Cannabis Sativa extract.
(text from Brazilian Governmental Official website)

Ministério da Saúde – ANVISA – 04NOV2021 (www.gov.br/anvisa/pt-br)

#cannabis
#cannabidiol
#cbd
#thc
#epilepsy
#sclerosis

First cannabis-based medicines approved for use on NHS

Charities welcome epilepsy and MS drugs but say thousands of people have been left in limbo.

The Guardian – 11NOV2019 (theguardian.com)

#cannabis
#cannabidiol
#cbd
#thc
#epilepsy
#sclerosis

Licensing of Promediol™ CBD FULL Spectrum / CANNABIS SATIVA PROMEDIOL EXTRACT – 50mg/mL, for BIOLAB SANUS SA.

Brazilian BIOLAB SANUS bets on mental health and starts distributing Promediol™ cannabis sativa extract to pharmacies across the country. (text from brazilian newspaper O Estado de São Paulo, in portuguese)

O Estado de São Paulo – 07JUN2022 (www.estadao.com.br)

#cannabis
#cannabidiol
#cbd
#thc
#epilepsy
#sclerosis

Licensing of Promediol™ CBD FULL Spectrum / CANNABIS SATIVA PROMEDIOL EXTRACT – 50mg/mL, for BIOLAB SANUS SA.

Brazilian BIOLAB SANUS launches Cannabis extract, imported by Promediol® do Brasil, on pharmacies across the country. (text from brazilian newspaper Diário da Manhã, in portuguese)

Diário da Manhã – 06JUN2022 (www.dm.com.br)

#cannabis
#cannabidiol
#cbd
#thc
#epilepsy
#sclerosis